SB 5020 – Washington

Status: Inactive / Dead
Year Introduced: 2021
Link: https://app.leg.wa.gov/billsummary?BillNumber=5020&Year=2021&Initiative=false

Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents. Requires the Health Care Authority to assess a penalty against a drug manufacturer on revenue generated from a price increase on a prescription drug that is not supported by clinical evidence; prohibits manufacturers from withdrawing a drug from the market to avoid paying the penalty.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found